Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sputum”

346 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 346 results

Not applicableEnrolling By InvitationNCT04579211
What this trial is testing

Prospective Analysis of Urine LAM to Eliminate NTM Sputum Screening

Who this might be right for
Cystic Fibrosis
Jerry A. Nick, M.D. 220
Not applicableStudy completedNCT02495597
What this trial is testing

LCI and Bronchial Inflammation in Patients With BO

Who this might be right for
Bronchiolitis Obliterans
Johann Wolfgang Goethe University Hospital 37
Testing effectiveness (Phase 2)UnknownNCT06482294
What this trial is testing

CIVETTA: Correlating Inflammatory Values of FEno, SympToms, SpuTum and Lung Function in Asthma

Who this might be right for
Asthma
Università degli Studi di Ferrara 80
Not applicableUnknownNCT01224977
What this trial is testing

Development and Validation of a Sputum Biomarker mRNA Panel for the Diagnostic Work-up of Asthma 4.

Who this might be right for
Asthmatic Patients
Universitaire Ziekenhuizen KU Leuven 20
Not applicableStudy completedNCT01543516
What this trial is testing

Cell Distribution in Induced Sputum in Patients With Asthma

Who this might be right for
Bronchial Asthma With eNO-levels Greater Than 30 ppB
Johann Wolfgang Goethe University Hospital 40
Testing effectiveness (Phase 2)Study completedNCT03428334
What this trial is testing

Roflumilast in Non-CF Bronchiectasis Study

Who this might be right for
Non-cystic Fibrosis Bronchiectasis
The University of Hong Kong 20
Testing effectiveness (Phase 2)Study completedNCT02522299
What this trial is testing

Evaluate the Safety, Efficacy and Changes in Induced Sputum and Blood Biomarkers Following Daily Repeat Doses of Inhaled GSK2269557 in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Acute Exacerbation

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 44
Not applicableStudy completedNCT01611012
What this trial is testing

The Development of a Clinical Test to Assess the Inflammatory Phenotype of Asthma

Who this might be right for
Asthma
Prof. Jan-Willem Lammers MD PhD 115
Testing effectiveness (Phase 2)Study completedNCT00910871
What this trial is testing

To Evaluate the Safety, Tolerability, and Efficacy of TMC207 as Part of an Individualized Multi-drug Resistant Tuberculosis (MDR-TB) Treatment Regimen in Participants With Sputum Smear-positive Pulmonary MDR-TB.

Who this might be right for
Tuberculosis
Janssen Infectious Diseases BVBA 241
Post-approval studies (Phase 4)Ended earlyNCT00158847
What this trial is testing

Modification Of Disease Outcome In COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease
Leiden University Medical Center 200
Testing effectiveness (Phase 2)Study completedNCT02130635
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Dose-Response Relationship of Multiple Doses of GSK2269557 Administered as a Dry Powder to Chronic Obstructive Pulmonary Disease (COPD) Patients

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 64
Early research (Phase 1)Ended earlyNCT01068145
What this trial is testing

Two-Part Study to Evaluate the Dose Response of SCH 527123 on Sputum Neutrophilia Following Ozone Challenge in Healthy Subjects and Chronic Obstructive Pulmonary Disease (COPD) Patients (P05567 AM7)

Who this might be right for
Chronic Obstructive Pulmonary Disease
Merck Sharp & Dohme LLC 18
Not applicableWithdrawnNCT00159289
What this trial is testing

Endotoxin and Inflammatory Markers in Healthy Non-Smokers and Current Smokers Including Patients With Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease
Imperial College London
Not applicableStudy completedNCT00906568
What this trial is testing

Evaluation of Bronchial Inflammation in Allergic Bronchopulmonary Aspergillosis (ABPA)

Who this might be right for
Cystic Fibrosis,
Johann Wolfgang Goethe University Hospital 40
Early research (Phase 1)Study completedNCT04032535
What this trial is testing

Investigate the Safety, Tolerability and Pharmacokinetics of CHF6523 in Healthy and in COPD Subjects

Who this might be right for
COPD
Chiesi Farmaceutici S.p.A. 136
Not applicableLooking for participantsNCT06508008
What this trial is testing

Rapid and Safe Sputum Suction Method Validation

Who this might be right for
Sputum
Affiliated Hospital of Nantong University 900
Not applicableLooking for participantsNCT00471250
What this trial is testing

Collection of Lung Fluid and Tissue Samples for Research

Who this might be right for
Leukocyte DisordersRespiratory Tract DiseasesBronchoscopy
National Heart, Lung, and Blood Institute (NHLBI) 550
Not applicableStudy completedNCT01580332
What this trial is testing

Non-Invasive Biomarkers For Early Detection Of Lung Cancers

Who this might be right for
Lung Cancer
Douglas W. Johnson MD, FACR 50
Post-approval studies (Phase 4)UnknownNCT01121016
What this trial is testing

Efficacy and Safety of add-on Montelukast to Inhaled Budesonide in the Treatment of Nonasthmatic Eosinophilic Bronchitis

Who this might be right for
Nonasthmatic Eosinophilic Bronchitis
Guangzhou Medical University 63
Testing effectiveness (Phase 2)Study completedNCT01225640
What this trial is testing

PNU-100480 In Newly Diagnosed, Drug Sensitive Patients With Pulmonary TB; Early Bactericidal Activity; Whole Blood Assay

Who this might be right for
Tuberculosis
Sequella, Inc. 59
Next Page